Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General news updates Wayanad landslides: Death toll climbs to 108 as rescue efforts intensify In a devastating blow to Kerala, the Wayanad district has been struck by one of the worst natural… byPallavi MadhirajuJuly 30, 2024